Literature DB >> 20610652

Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.

Mourad Zerfaoui1, Youssef Errami, Amarjit S Naura, Yasuhiro Suzuki, Hogyoung Kim, Jihang Ju, Tao Liu, Chetan P Hans, Jong G Kim, Zakaria Y Abd Elmageed, Shahriar Koochekpour, Andrew Catling, A Hamid Boulares.   

Abstract

The role of NF-kappaB in the expression of inflammatory genes and its participation in the overall inflammatory process of chronic diseases and acute tissue injury are well established. We and others have demonstrated a critical involvement of poly(ADP-ribose) polymerase (PARP)-1 during inflammation, in part, through its relationship with NF-kappaB. However, the mechanism by which PARP-1 affects NF-kappaB activation has been elusive. In this study, we show that PARP-1 inhibition by gene knockout, knockdown, or pharmacologic blockade prevented p65 NF-kappaB nuclear translocation in smooth muscle cells upon TLR4 stimulation, NF-kappaB DNA-binding activity, and subsequent inducible NO synthase and ICAM-1 expression. Such defects were reversed by reconstitution of PARP-1 expression. PARP-1 was dispensable for LPS-induced IkappaBalpha phosphorylation and subsequent degradation but was required for p65 NF-kappaB phosphorylation. A perinuclear p65 NF-kappaB localization in LPS-treated PARP-1(-/-) cells was associated with an export rather an import defect. Indeed, whereas PARP-1 deficiency did not alter expression of importin alpha3 and importin alpha4 and their cytosolic localization, the cytosolic levels of exportin (Crm)-1 were increased. Crm1 inhibition promoted p65 NF-kappaB nuclear accumulation as well as reversed LPS-induced p65 NF-kappaB phosphorylation and inducible NO synthase and ICAM-1 expression. Interestingly, p65 NF-kappaB poly(ADP-ribosyl)ation decreased its interaction with Crm1 in vitro. Pharmacologic inhibition of PARP-1 increased p65 NF-kappaB-Crm1 interaction in LPS-treated smooth muscle cells. These results suggest that p65 NF-kappaB poly(ADP-ribosyl)ation may be a critical determinant for the interaction with Crm1 and its nuclear retention upon TLR4 stimulation. These results provide novel insights into the mechanism by which PARP-1 promotes NF-kappaB nuclear retention, which ultimately can influence NF-kappaB-dependent gene regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610652      PMCID: PMC2910824          DOI: 10.4049/jimmunol.1000646

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Role of the NF-kappaB pathway in the pathogenesis of human disease states.

Authors:  Y Yamamoto; R B Gaynor
Journal:  Curr Mol Med       Date:  2001-07       Impact factor: 2.222

2.  Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

Authors:  H C Ha; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis.

Authors:  A H Boulares; A J Zoltoski; A Yakovlev; M Xu; M E Smulson
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

Review 4.  NF-kappaB in cancer: from innocent bystander to major culprit.

Authors:  Michael Karin; Yixue Cao; Florian R Greten; Zhi-Wei Li
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

5.  The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function.

Authors:  P O Hassa; M Covic; S Hasan; R Imhof; M O Hottiger
Journal:  J Biol Chem       Date:  2001-10-04       Impact factor: 5.157

6.  Regulation of DNAS1L3 endonuclease activity by poly(ADP-ribosyl)ation during etoposide-induced apoptosis. Role of poly(ADP-ribose) polymerase-1 cleavage in endonuclease activation.

Authors:  A Hamid Boulares; Anna J Zoltoski; Francisco J Contreras; Alexander G Yakovlev; Koichiro Yoshihara; Mark E Smulson
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

Review 7.  Physiology and pathophysiology of poly(ADP-ribosyl)ation.

Authors:  A Bürkle
Journal:  Bioessays       Date:  2001-09       Impact factor: 4.345

Review 8.  Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited.

Authors:  Alberto Chiarugi
Journal:  Trends Pharmacol Sci       Date:  2002-03       Impact factor: 14.819

Review 9.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

10.  Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress.

Authors:  Chetan P Hans; Yumei Feng; Amarjit S Naura; Mourad Zerfaoui; Bashir M Rezk; Huijing Xia; Alan D Kaye; Khalid Matrougui; Eric Lazartigues; A Hamid Boulares
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more
  82 in total

1.  PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.

Authors:  R Datta; A S Naura; M Zerfaoui; Y Errami; M Oumouna; H Kim; J Ju; V P Ronchi; A L Haas; A H Boulares
Journal:  Allergy       Date:  2011-01-28       Impact factor: 13.146

2.  Identification of poly (ADP-ribose) polymerase-1 (PARP-1) as a novel Kruppel-like factor 8-interacting and -regulating protein.

Authors:  Heng Lu; Xianhui Wang; Tianshu Li; Alison M Urvalek; Lin Yu; Jieli Li; Jinghua Zhu; Qishan Lin; Xu Peng; Jihe Zhao
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.

Authors:  Kaiyu Yuan; Yong Sun; Tong Zhou; Jay McDonald; Yabing Chen
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

5.  Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice.

Authors:  Modar Kassan; Soo-Kyoung Choi; Maria Galán; Mohamed Trebak; Souad Belmadani; Khalid Matrougui
Journal:  Diabetes Metab Res Rev       Date:  2015-01       Impact factor: 4.876

6.  Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.

Authors:  Manish Mishra; Renu A Kowluru
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-03       Impact factor: 5.187

Review 7.  Atomic basis of CRM1-cargo recognition, release and inhibition.

Authors:  Ho Yee Joyce Fung; Yuh Min Chook
Journal:  Semin Cancer Biol       Date:  2014-03-12       Impact factor: 15.707

8.  Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis.

Authors:  Youssef Errami; Amarjit S Naura; Hogyoung Kim; Jihang Ju; Yasuhiro Suzuki; Ali H El-Bahrawy; Mohamed A Ghonim; Ramadan A Hemeida; Moselhy S Mansy; Jianhua Zhang; Ming Xu; Mark E Smulson; Hassan Brim; A Hamid Boulares
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

Review 9.  Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Authors:  Maria Manuela Rosado; Elisabetta Bennici; Flavia Novelli; Claudio Pioli
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

10.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.